Pilot Study of the Treatment of Vascular Endothelial Growth Factor(VEGF)Signaling Pathway Inhibitor-Induced Hypertension

NCT00607477 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Study has been terminated due to poor accrual.

Conditions

Treatment Induced Hypertension

Interventions

DRUG: Minoxidil
DRUG: Hydralazine

Sponsor

University of Chicago